$ACAN
AmeriCann, Inc. Stock $acan

$acan Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000143774918015624 Filed on August 14, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue		$10.00K
YoY Change		-77.78%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$430.0K	$400.0K
YoY Change	7.5%	42.86%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$434.3K	$397.1K
YoY Change	9.39%	40.19%
Operating Profit	-$434.3K	-$387.1K
YoY Change	12.22%	62.48%
Interest Expense	$830.2K	$44.41K
YoY Change	1769.28%	-9.04%
% of Operating Profit
Other Income/Expense, Net	-$851.7K	-$81.01K
YoY Change	951.31%
Pretax Income	-$1.290M	-$470.0K
YoY Change	174.47%	30.56%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.286M	-$468.1K
YoY Change	174.75%	31.34%
Net Earnings / Revenue		-4680.71%
Basic Earnings Per Share
Diluted Earnings Per Share	-$66.32K	-$24.43K
COMMON SHARES
Basic Shares Outstanding	19.45M	19.24M
Diluted Shares Outstanding	19.45M	19.24M

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.010M	$10.00K
YoY Change	10000.0%	0.0%
Cash & Equivalents	$1.006M	$10.42K
Short-Term Investments
Other Short-Term Assets	$370.0K	$90.00K
YoY Change	311.11%	-74.29%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.375M	$100.1K
YoY Change	1273.87%	-72.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.074K	$4.434K
YoY Change	36.99%	-55.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.740M	$5.050M
YoY Change	-45.74%	69.46%
Total Long-Term Assets	$4.599M	$6.615M
YoY Change	-30.48%	72.92%
TOTAL ASSETS
Total Short-Term Assets	$1.375M	$100.1K
Total Long-Term Assets	$4.599M	$6.615M
Total Assets	$5.974M	$6.715M
YoY Change	-11.04%	60.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.00K	$390.0K
YoY Change	-84.62%	39.29%
Accrued Expenses	$10.00K	$0.00
YoY Change		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$520.0K	$990.0K
YoY Change	-47.47%	-71.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$610.6K	$1.396M
YoY Change	-56.26%	-63.16%
LONG-TERM LIABILITIES
Long-Term Debt	$1.960M	$1.980M
YoY Change	-1.01%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.960M	$1.980M
YoY Change	-1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$610.6K	$1.396M
Total Long-Term Liabilities	$1.960M	$1.980M
Total Liabilities	$2.573M	$3.380M
YoY Change	-23.87%	-10.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.26M	-$7.403M
YoY Change	65.61%	69.17%
Common Stock	$2.044K	$1.937K
YoY Change	5.52%	16.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.401M	$3.335M
YoY Change
Total Liabilities & Shareholders Equity	$5.974M	$6.715M
YoY Change	-11.04%	60.52%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$1.286M	-$468.1K
YoY Change	174.75%	31.34%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$320.0K	-$350.0K
YoY Change	-8.57%	75.0%
INVESTING ACTIVITIES
Capital Expenditures	-$190.0K	-$260.0K
YoY Change	-26.92%	-7.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$40.00K
YoY Change	-100.0%	300.0%
Cash From Investing Activities	-$190.0K	-$220.0K
YoY Change	-13.64%	-15.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	950.0K	370.0K
YoY Change	156.76%	-9.76%
NET CHANGE
Cash From Operating Activities	-320.0K	-350.0K
Cash From Investing Activities	-190.0K	-220.0K
Cash From Financing Activities	950.0K	370.0K
Net Change In Cash	440.0K	-200.0K
YoY Change	-320.0%	300.0%
FREE CASH FLOW
Cash From Operating Activities	-$320.0K	-$350.0K
Capital Expenditures	-$190.0K	-$260.0K
Free Cash Flow	-$130.0K	-$90.00K
YoY Change	44.44%	-212.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	acan	Class Of Warrant Or Right Cancelled During Period ClassOfWarrantOrRightCancelledDuringPeriod	1800000
	acan	Class Of Warrant Or Right Cancelled During Period Exercise Price ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice	9.33
CY2018Q2	acan	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	5675000
CY2018Q2	acan	Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value ClassOfWarrantOrRightExercisableAggregateIntrinsicValue	6505500
CY2018Q2	acan	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	2.35
	acan	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm	P2Y328D
	acan	Amortization Of Equity Instruments Issued To Lessor AmortizationOfEquityInstrumentsIssuedToLessor	28979
	acan	Amortization Of Equity Instruments Issued To Lessor AmortizationOfEquityInstrumentsIssuedToLessor
CY2017Q3	acan	Assets Heldforsale Not Part Of Disposal Group Noncurrent AssetsHeldforsaleNotPartOfDisposalGroupNoncurrent	1611312
	acan	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	200000
	acan	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.13
	acan	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	791000
	acan	Class Of Warrant Or Right Expired During Period Exercise Price ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice	8
	acan	Class Of Warrant Or Right Granted During Period ClassOfWarrantOrRightGrantedDuringPeriod	2040000
	acan	Class Of Warrant Or Right Granted During Period Exercise Price ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice	1.50
	acan	Class Of Warrant Or Right Granted Weighted Average Remaining Contract Term ClassOfWarrantOrRightGrantedWeightedAverageRemainingContractTerm	P4Y292D
CY2018Q2	acan	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue	15618500
CY2017	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P2Y146D
	acan	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P2Y255D
CY2018Q2	acan	Class Of Warrant Or Right Vested And Expected To Vest ClassOfWarrantOrRightVestedAndExpectedToVest	9415000
CY2018Q2	acan	Class Of Warrant Or Right Vested And Expected To Vest Aggregate Intrinsic Value ClassOfWarrantOrRightVestedAndExpectedToVestAggregateIntrinsicValue	15618500
CY2018Q2	acan	Class Of Warrant Or Right Vested And Expected To Vest Weighted Average Exercise Price ClassOfWarrantOrRightVestedAndExpectedToVestWeightedAverageExercisePrice	1.81
	acan	Class Of Warrant Or Right Vested And Expected To Vest Weighted Average Remaining Contract Term ClassOfWarrantOrRightVestedAndExpectedToVestWeightedAverageRemainingContractTerm	P2Y255D
CY2018Q2	acan	Notes Loans And Financing Receivable Net Related Parties Noncurrent NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent	172575
CY2018Q2	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	13934
CY2017Q3	acan	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	84998
CY2018Q2	acan	Land Held For Use LandHeldForUse
CY2017Q3	acan	Land Held For Use LandHeldForUse	1611312
CY2018Q2	acan	Notes And Loans Receivable Net NotesAndLoansReceivableNet	956480
CY2017Q3	acan	Notes And Loans Receivable Net NotesAndLoansReceivableNet	905642
	acan	Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature	2297438
	acan	Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature
CY2018Q2	acan	Debt Instrument Related Parties Unamortized Discount DebtInstrumentRelatedPartiesUnamortizedDiscount	31014
CY2017Q3	acan	Debt Instrument Related Parties Unamortized Discount DebtInstrumentRelatedPartiesUnamortizedDiscount	47037
CY2018Q2	acan	Depoists On Land Noncurrent DepoistsOnLandNoncurrent	2738578
CY2017Q3	acan	Depoists On Land Noncurrent DepoistsOnLandNoncurrent	2782047
	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	-71064
	acan	Increase Decrease In Interest Payable Related Party Net IncreaseDecreaseInInterestPayableRelatedPartyNet	-109825
CY2016Q4	acan	Number Of Units Sold NumberOfUnitsSold	2000000
CY2017Q3	acan	Notes Loans And Financing Receivable Net Related Parties Noncurrent NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent	125327
CY2016Q4	acan	Number Of Common Shares In Each Unit NumberOfCommonSharesInEachUnit	1
CY2016Q4	acan	Number Of Warrants In Each Unit NumberOfWarrantsInEachUnit	1
CY2014Q1	acan	Ownership Percentage Transfered OwnershipPercentageTransfered	0.93
	acan	Proceeds From Sale Of Land Used To Satisfy Debt Obligations ProceedsFromSaleOfLandUsedToSatisfyDebtObligations	1608451
	acan	Proceeds From Sale Of Land Used To Satisfy Debt Obligations ProceedsFromSaleOfLandUsedToSatisfyDebtObligations
CY2018Q2	acan	Security Deposit And Other Noncurrent Assets SecurityDepositAndOtherNoncurrentAssets	3110
CY2017Q3	acan	Security Deposit And Other Noncurrent Assets SecurityDepositAndOtherNoncurrentAssets	3110
	acan	Stock And Warrants Issued During Period Value Consideration For Sale Leaseback Transaction StockAndWarrantsIssuedDuringPeriodValueConsiderationForSaleLeasebackTransaction
	acan	Stock And Warrants Issued During Period Value Consideration For Sale Leaseback Transaction StockAndWarrantsIssuedDuringPeriodValueConsiderationForSaleLeasebackTransaction	1972966
	acan	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	200000
CY2018Q2	acan	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	200000
	acan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	225000
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	61641
CY2017Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	624623
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4546
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3704
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15658209
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10959188
CY2018Q2	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	977770
CY2017Q3	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	977770
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1840745
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14977
CY2014Q3	us-gaap	Area Of Land AreaOfLand	5
CY2018Q2	us-gaap	Area Of Land AreaOfLand	5
CY2018Q2	us-gaap	Assets Assets	5974043
CY2017Q3	us-gaap	Assets Assets	6063558
CY2018Q2	us-gaap	Assets Current AssetsCurrent	1375281
CY2017Q3	us-gaap	Assets Current AssetsCurrent	64586
CY2018Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	39195
CY2017Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	28820
CY2018Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2305
CY2017Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	12680
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1006310
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10418
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1627
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1627
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1309822
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10418
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1308195
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10394
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.68
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.81
CY2018Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2040000
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10166000
CY2018Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9415000
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20430215
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19366000
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20430215
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19366000
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	2044
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	1937
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	166660
CY2018Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	892215
CY2017Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	680028
CY2018Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	802741
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	802741
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2018Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	535161
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	510671
CY2017Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11218
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11217
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	357224
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	344710
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1149678
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2861
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	997960
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-536217
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-160659
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	40838
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2521
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-30000
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-10000
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	27849
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-8924
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8997
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-277
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-11990
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-23470
CY2018Q2	us-gaap	Interest Expense InterestExpense	830204
CY2017Q2	us-gaap	Interest Expense InterestExpense	44413
	us-gaap	Interest Expense InterestExpense	2009192
	us-gaap	Interest Expense InterestExpense	183750
CY2018Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	36926
CY2017Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	36925
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	110777
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	106527
	us-gaap	Interest Paid Net InterestPaidNet	322438
	us-gaap	Interest Paid Net InterestPaidNet	394049
CY2018Q2	us-gaap	Interest Payable Current InterestPayableCurrent	13934
CY2017Q3	us-gaap	Interest Payable Current InterestPayableCurrent	86253
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	15453
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	327
	us-gaap	Investment Income Interest InvestmentIncomeInterest	40839
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11086
CY2017Q3	us-gaap	Land Land	1611312
CY2018Q2	us-gaap	Liabilities Liabilities	2573267
CY2017Q3	us-gaap	Liabilities Liabilities	3779258
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5974043
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6063558
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	610607
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1800575
CY2018Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9300
CY2017Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1945
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	13049
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9165
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7500
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	214951
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	472023
CY2014Q3	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	2250809
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5000
CY2018Q2	us-gaap	Prepaid Rent PrepaidRent	57959
CY2017Q3	us-gaap	Prepaid Rent PrepaidRent	57959
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	277378
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3416485
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1990527
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-214951
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-292279
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1893339
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1687854
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1286020
	us-gaap	Net Income Loss NetIncomeLoss	-3582652
	us-gaap	Net Income Loss NetIncomeLoss	-1497804
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-468071
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-851677
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-81011
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2081991
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-279191
CY2018Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	783905
CY2017Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	780315
CY2018Q2	us-gaap	Notes Payable Current NotesPayableCurrent	524330
CY2017Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1070000
CY2018Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1962660
CY2017Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1978683
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	434343
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	397060
	us-gaap	Operating Expenses OperatingExpenses	1500661
	us-gaap	Operating Expenses OperatingExpenses	1258613
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-434343
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-387060
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1500661
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1218613
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2861
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
CY2018Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	10702
CY2017Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	19699
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	922412
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2176274
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2536000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	24657
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-67634
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18750
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37500
CY2018Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	225000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	225000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2018Q2	us-gaap	Professional Fees ProfessionalFees	67819
CY2017Q2	us-gaap	Professional Fees ProfessionalFees	50405
	us-gaap	Professional Fees ProfessionalFees	337934
	us-gaap	Professional Fees ProfessionalFees	251488
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6074
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4153
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	285677
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	227904
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	20000
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	303512
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12259477
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8676825
CY2018Q2	us-gaap	Revenues Revenues
CY2017Q2	us-gaap	Revenues Revenues	10000
	us-gaap	Revenues Revenues
	us-gaap	Revenues Revenues	40000
	us-gaap	Share Based Compensation ShareBasedCompensation	432787
	us-gaap	Share Based Compensation ShareBasedCompensation	37450
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1100000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	431200
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1305000
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	180000
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.29
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.21
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	180000
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.21
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	180000
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.21
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.75
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.45
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	223500
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P219D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y219D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y219D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y219D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	3400776
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	2284300
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19447377
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19239465
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19396514
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18886513
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19447377
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19239465
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19396514
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18886513
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19447377
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19239465
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19396514
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18886513

Files In Submission

Name	View Source	Status
0001437749-18-015624-index-headers.html	Edgar Link	pending
0001437749-18-015624-index.html	Edgar Link	pending
0001437749-18-015624.txt	Edgar Link	pending
0001437749-18-015624-xbrl.zip	Edgar Link	pending
acan-20180630.xml	Edgar Link	completed
acan-20180630.xsd	Edgar Link	pending
acan-20180630_cal.xml	Edgar Link	unprocessable
acan-20180630_def.xml	Edgar Link	unprocessable
acan-20180630_lab.xml	Edgar Link	unprocessable
acan-20180630_pre.xml	Edgar Link	unprocessable
acan20180630_10q.htm	Edgar Link	pending
ex_121078.htm	Edgar Link	pending
ex_121079.htm	Edgar Link	pending
ex_121080.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACAN
AmeriCann, Inc. Stock $acan

2018 Q2 Form 10-Q Financial Statement

#000143774918015624 Filed on August 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN AmeriCann, Inc. Stock $acan

2018 Q2 Form 10-Q Financial Statement

#000143774918015624 Filed on August 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACAN
AmeriCann, Inc. Stock $acan